| Dr Alexandra Jouk, | |
|
375 Laguna Honda Blvd, San Francisco, CA 94116 | |
| (415) 759-2300 | |
| Not Available |
| Full Name | Dr Alexandra Jouk |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Rehabilitation |
| Location | 375 Laguna Honda Blvd, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023507084 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 29275 (California) | Secondary |
| 103TR0400X | Psychologist - Rehabilitation | 29275 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexandra Jouk, 375 Laguna Honda Blvd, San Francisco, CA 94116-1499 Ph: () - | Dr Alexandra Jouk, 375 Laguna Honda Blvd, San Francisco, CA 94116 Ph: (415) 759-2300 |
News Archive
BeiGene (Beijing), Co., Ltd., today announced dose administration for the first patient in a Phase 1 study of BGB-283 in patients with B-RAF or K-RAS mutations. BGB-283 is an investigational, oral, selective, potent second generation inhibitor of B-RAF, making it a targeted therapeutic candidate to potentially treat and bring benefit to patients with cancers that harbor BRAF mutations and/or aberrations in the RAS-MAPK (mitogen-activated protein kinase) pathway.
Inspirion Delivery Technologies, LLC ("IDT") announced today that last week the Company completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to determine the clinical and regulatory pathway to advance its abuse deterrent, extended release formulation of oxycodone.
Al Jazeera examines HIV/AIDS in the Persian Gulf, writing, "For much of the past two decades, there has been an information vacuum in the Gulf for epidemiological data on HIV and AIDS.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured a further AU$6.25 million of venture capital investment from GBS Venture Partners Limited, Brandon Capital Partners Pty Limited, Uniseed Management Pty Limited and UniQuest Pty Limited to fund the development of its pain management drug, EMA401.
Their numbers are rising, but their age is dropping: children and young adults who drink so much that they have to go to the hospital. Binge-drinking is sadly fashionable amongst the under 20-year-olds. But how can adolescents be effectively protected from alcohol and substance abuse?
› Verified 3 days ago
B L. Elliott, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 747 Front St, San Francisco, CA 94111 Phone: 707-508-6341 | |
Dr. David Tim Lewis, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 703 Market St Ste 1208, San Francisco, CA 94103 Phone: 415-350-9611 | |
Candy Ho Katoa, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 401 Parnassus Ave, Lp 488, San Francisco, CA 94143 Phone: 415-476-7133 | |
Stephanie Lauren Post, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1630 Lombard St, San Francisco, CA 94123 Phone: 703-901-6833 | |
Anett Atman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3600 California St, San Francisco, CA 94118 Phone: 415-820-9612 | |
Dr. Andrea Samuels, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1947 Divisadero St Ste 1d, San Francisco, CA 94115 Phone: 510-847-4858 | |
Timothy Kim, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1610 Scott St, San Francisco, CA 94115 Phone: 510-365-5066 |